2601.14701v1.pdf

{
  "file/base": {
    "record": {
      "extension": ".pdf",
      "hash": "18a1803498eaa358684a31d171e95066c675dcc01b2d557d20c1820e59d84420",
      "media_type": "application/pdf",
      "media_type_prefix": "application",
      "name": "2601.14701v1.pdf",
      "size": 528386
    },
    "source": {
      "execution_id": "6af0364b-d4d4-4aa0-bb19-6bf53fccfad0",
      "id": "file/base",
      "type": "Model",
      "version": "1.0.0"
    }
  },
  "file/pdf": {
    "private": false,
    "record": {
      "keywords": [],
      "page_count": 30,
      "producer": "pikepdf 8.15.1",
      "title": "Regulatory Expectations for Bayesian Methods in Drug and Biologic Clinical Trials: A Practical Perspective on FDA\u0027s 2026 Draft Guidance",
      "version": "1.7"
    },
    "source": {
      "execution_id": "153f3947-6b6f-4a19-af16-b705703a4019",
      "id": "dorsal/pdf",
      "type": "Model",
      "version": "1.1.0"
    }
  }
}